• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身抗体促进自身免疫性血管性水肿中C1抑制物的裂解。

Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.

作者信息

Jackson J, Sim R B, Whaley K, Feighery C

机构信息

Department of Immunology, St. James Hospital, Dublin, Ireland.

出版信息

J Clin Invest. 1989 Feb;83(2):698-707. doi: 10.1172/JCI113934.

DOI:10.1172/JCI113934
PMID:2536404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC303731/
Abstract

C1-inhibitor (C1-Inh) is an important inhibitor of the inflammatory response and deficiency of this inhibitor, which may be hereditary or acquired, is associated with recurrent episodes of edema. Recently, an autoimmune form of angioedema has been described that is associated with functional deficiency of C1-Inh and an autoantibody that impedes C1-Inh function. In this report we describe the isolation of C1-Inh from the monocytes and plasma of a patient with autoimmune angioedema and demonstrate that the patient's monocytes secrete structurally and functionally normal C1-Inh, but show that this protein circulates in the patient's plasma in an inactive, structurally altered form. Furthermore, using analytic gel electrophoresis techniques it is demonstrated that the patient's autoantibody facilitates cleavage of normal C1-Inh, by its target proteases, to the same species of C1-Inh that is found circulating in the patient's plasma. This autoantibody facilitated cleavage of normal C1-Inh is apparently a consequence of destabilization of protease/inhibitor complexes. These findings contribute to our understanding of protease/C1-Inh interactions and document important observations on pathogenic mechanisms in autoimmune disease.

摘要

C1抑制剂(C1-Inh)是炎症反应的一种重要抑制剂,该抑制剂的缺乏(可能是遗传性的或后天获得的)与反复出现的水肿发作有关。最近,已描述了一种自身免疫性血管性水肿,它与C1-Inh的功能缺陷以及一种阻碍C1-Inh功能的自身抗体有关。在本报告中,我们描述了从一名自身免疫性血管性水肿患者的单核细胞和血浆中分离出C1-Inh的过程,并证明该患者的单核细胞分泌结构和功能正常的C1-Inh,但表明这种蛋白质在患者血浆中以无活性的、结构改变的形式循环。此外,使用分析凝胶电泳技术证明,患者的自身抗体通过其靶蛋白酶促进正常C1-Inh裂解为在患者血浆中循环的同一种C1-Inh。这种自身抗体促进的正常C1-Inh裂解显然是蛋白酶/抑制剂复合物不稳定的结果。这些发现有助于我们理解蛋白酶/C1-Inh相互作用,并记录了自身免疫性疾病致病机制的重要观察结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/626c3324bffd/jcinvest00083-0356-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/afc68ba902de/jcinvest00083-0353-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/cb0e5c4ce25a/jcinvest00083-0353-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/732635819cb0/jcinvest00083-0353-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/15495ba57d03/jcinvest00083-0354-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/3ab3b4fd8c3f/jcinvest00083-0354-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/fb841cf21a05/jcinvest00083-0355-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/662bbd2ca19f/jcinvest00083-0356-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/626c3324bffd/jcinvest00083-0356-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/afc68ba902de/jcinvest00083-0353-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/cb0e5c4ce25a/jcinvest00083-0353-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/732635819cb0/jcinvest00083-0353-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/15495ba57d03/jcinvest00083-0354-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/3ab3b4fd8c3f/jcinvest00083-0354-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/fb841cf21a05/jcinvest00083-0355-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/662bbd2ca19f/jcinvest00083-0356-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99cc/303731/626c3324bffd/jcinvest00083-0356-b.jpg

相似文献

1
Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.自身抗体促进自身免疫性血管性水肿中C1抑制物的裂解。
J Clin Invest. 1989 Feb;83(2):698-707. doi: 10.1172/JCI113934.
2
Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitor.血管紧张素转换酶抑制剂引发获得性自身免疫性C1抑制物缺乏症
Ann Allergy Asthma Immunol. 2001 Apr;86(4):461-4. doi: 10.1016/S1081-1206(10)62496-9.
3
The acquired C1-INH deficiencies with autoantibodies (AAE type II).伴有自身抗体的获得性C1抑制物缺乏症(II型自身免疫性血管性水肿)
Behring Inst Mitt. 1989 Jul(84):165-72.
4
Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.获得性C1抑制剂(C1-INH)Ⅱ型缺乏症。C1-INH替代疗法及患者C1-INH和抗C1-INH自身抗体分析。
J Clin Invest. 1989 Jun;83(6):1794-9. doi: 10.1172/JCI114084.
5
Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema.一例获得性血管性水肿患者体内针对C1抑制剂的多克隆自身抗体
Ann Allergy Asthma Immunol. 2002 Jun;88(6):632-7. doi: 10.1016/S1081-1206(10)61896-0.
6
Urticaria, angioedema, and autoimmunity.荨麻疹、血管性水肿与自身免疫
Clin Lab Med. 1997 Sep;17(3):559-69.
7
A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus.一种与系统性红斑狼疮相关的新型获得性C1抑制剂缺乏症。
Arthritis Rheum. 2001 Aug;44(8):1836-40. doi: 10.1002/1529-0131(200108)44:8<1836::AID-ART321>3.0.CO;2-Y.
8
Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
J Immunol. 1994 Mar 15;152(6):3199-209.
9
[Angioedema due to acquired complement-C1-inhibitor deficiency in a female patient with non-Hodgkin lymphoma and autoimmune hemolytic anemia].[一名患有非霍奇金淋巴瘤和自身免疫性溶血性贫血的女性患者因获得性补体C1抑制物缺乏导致血管性水肿]
Schweiz Med Wochenschr. 1991 Jun 22;121(25):943-7.
10
Interactions of plasma kallikrein and C1-s with normal and dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema: analytic gel studies.血浆激肽释放酶和C1-s与遗传性血管性水肿患者正常及功能失调的C1(-) -抑制剂蛋白的相互作用:分析凝胶研究
Blood. 1987 Apr;69(4):1096-101.

引用本文的文献

1
Acquired Angioedema in Selected Neoplastic Diseases.某些肿瘤性疾病相关获得性血管性水肿。
Medicina (Kaunas). 2023 Mar 24;59(4):644. doi: 10.3390/medicina59040644.
2
The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.自身免疫性疾病中补体蛋白和固有免疫的免疫病理学。
Clin Rev Allergy Immunol. 2020 Apr;58(2):229-251. doi: 10.1007/s12016-019-08774-5.
3
Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema.利妥昔单抗治疗1例低度B细胞淋巴增殖性疾病合并获得性血管性水肿患者。

本文引用的文献

1
The C1 esterase inhibitor and hereditary angioedema.C1酯酶抑制剂与遗传性血管性水肿
J Clin Immunol. 1982 Apr;2(2):65-8. doi: 10.1007/BF00916888.
2
Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.关于人C1酯酶抑制剂与C1s相互作用的结构和圆二色性研究
Biochem J. 1983 Sep 1;213(3):617-24. doi: 10.1042/bj2130617.
3
Heparin-stimulated modification of C1-inhibitor by subcomponent C1s of human complement.肝素刺激下人补体C1s亚成分对C1抑制物的修饰作用。
J Asthma Allergy. 2014 Dec 2;7:165-7. doi: 10.2147/JAA.S68548. eCollection 2014.
4
Angioedema.血管性水肿。
World Allergy Organ J. 2008 Jun;1(6):103-13. doi: 10.1097/WOX.0b013e31817aecbe.
5
The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human.蛋白酶抑制剂α-2-巨球蛋白样-1 是人类副肿瘤天疱疮自身抗体识别的 p170 抗原。
PLoS One. 2010 Aug 18;5(8):e12250. doi: 10.1371/journal.pone.0012250.
6
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.遗传性和获得性血管性水肿:问题与进展:第三届C1酯酶抑制剂缺乏症研讨会及后续会议论文集
J Allergy Clin Immunol. 2004 Sep;114(3 Suppl):S51-131. doi: 10.1016/j.jaci.2004.06.047.
7
Mechanism of action of anti-C1-inhibitor autoantibodies: prevention of the formation of stable C1s-C1-inh complexes.抗C1抑制物自身抗体的作用机制:阻止稳定的C1s-C1抑制物复合物的形成。
Mol Med. 1998 Feb;4(2):119-28.
8
Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.纤溶酶对C1抑制物的降解作用:对炎症过程控制的影响。
Mol Med. 1997 Jun;3(6):385-96.
9
Antibody molecules: mediators of disease and diagnostic tools.抗体分子:疾病介质与诊断工具
Ir J Med Sci. 1989 Oct;158(10):245-52. doi: 10.1007/BF02943700.
Hoppe Seylers Z Physiol Chem. 1983 Mar;364(3):295-301.
4
The challenge of hereditary angioneurotic edema.遗传性血管性水肿的挑战。
N Engl J Med. 1983 May 5;308(18):1094-5. doi: 10.1056/NEJM198305053081810.
5
Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.遗传性血管性水肿中的前激肽释放酶激活和高分子量激肽原消耗
N Engl J Med. 1983 May 5;308(18):1050-3. doi: 10.1056/NEJM198305053081802.
6
Interaction of human plasma kallikrein and its light chain with C1 inhibitor.人血浆激肽释放酶及其轻链与C1抑制剂的相互作用。
Biochemistry. 1983 Sep 27;22(20):4860-6. doi: 10.1021/bi00289a037.
7
Human C1 inhibitor: improved isolation and preliminary structural characterization.人C1抑制剂:改进的分离方法及初步结构表征
Biochemistry. 1983 Oct 11;22(21):5001-7. doi: 10.1021/bi00290a019.
8
Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function.人α1-蛋白酶抑制剂。两种晶体变体的晶体结构分析、分子模型及功能影响的初步分析。
J Mol Biol. 1984 Aug 15;177(3):531-57.
9
Preparation and properties of human C1 inhibitor.人C1抑制剂的制备及其性质
Methods Enzymol. 1981;80 Pt C:43-54. doi: 10.1016/s0076-6879(81)80007-9.
10
The human complement system serine proteases C1r and C1s and their proenzymes.人类补体系统丝氨酸蛋白酶C1r和C1s及其酶原。
Methods Enzymol. 1981;80 Pt C:26-42. doi: 10.1016/s0076-6879(81)80006-7.